Akt1, but not Akt2, was shown to promote breast cancer cell proliferation by upregulating cyclin D1 and S6 (a downstream target of mTORC1) in IBH-6 and T47D breast cancer cells [70]. This evidence concerns the gene AKT2 and breast cancer.